Genoskin
Pre-clinicalGenoskin's technology maintains ex vivo human skin models alive and functional for at least 7 days. Let's accelerate science together!
Founded
2014
Focus
DermatologyDrug Delivery
About
Genoskin's technology maintains ex vivo human skin models alive and functional for at least 7 days. Let's accelerate science together!
Funding History
2Total raised: $20.5M
Series A$15MUndisclosedMay 15, 2022
Seed$5.5MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2014
LocationToulouse, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile